P2Y12 antagonist monotherapy
3-2017-0230
Unknown small_molecule completed
Quick answer
P2Y12 antagonist monotherapy for Coronary Artery Disease is a Unknown program (small_molecule) at Vera Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Vera Therapeutics
- Indication
- Coronary Artery Disease
- Phase
- Unknown
- Modality
- small_molecule
- Status
- completed